

Please try another search
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) announced positive data from the phase I ATI-450-PKPD-101 study on it investigational MK2 inhibitor, ATI-450, currently being developed for addressing...
Tyme Technologies, Inc. (NASDAQ:TYME) announced that it has dosed the first patient in part 2 of the pivotal study — TYME-88-Panc — evaluating lead cancer metabolism-based therapies...
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has rendered a positive opinion recommending a...
Almost every corner of the broader healthcare sector has been on a tear since October. Among the all industries, Pharmaceuticals gained the most in October itself, adding 8.7%. Pharma was followed by...
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) announced that it has sold worldwide rights to its rosacea drug, Rhofade Cream, and certain licenses to related intellectual property assets to...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is scheduled to release second-quarter 2019 results on Jul 6, before the opening bell.In the last reported quarter, the company missed earnings...
Bausch Health Companies Inc. (NYSE:BHC) is scheduled to report second-quarter 2019 results on Aug 6, before market open.In the last reported quarter, the company’s earnings beat estimates by...
Shares of Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) gained 3.3% on Jun 26 after the company’s lead drug, Doptelet, received marketing authorization from the European Commission for treating...
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has been struggling lately, but the selling pressure may be coming to an end soon. That is because RIGL recently saw a Hammer Chart Pattern which can signal...
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has enrolled the first patient in a pivotal phase III study evaluating Tavalisse (fostamatinib disodium hexahydrate) as a treatment for warm antibody...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review